TEK is a novel prognostic marker for clear cell renal cell carcinoma.

CONCLUSIONS: Although additional clinical investigations will be needed, our results suggest that TEK is a potential biomarker for ccRCC. PMID: 30840266 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30840266?dopt=Abstract

Source: European Review for Medical and Pharmacological Sciences - March 8, 2019 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research